|
1
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Amankwah EK, Conley AP and Reed DR:
Epidemiology and therapies for metastatic sarcoma. Clin Epidemiol.
5:147–162. 2013.PubMed/NCBI
|
|
3
|
Friedman MA and Carter SK: The therapy of
osteogenic sarcoma: Current status and thoughts for the future. J
Surg Oncol. 4:482–510. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peiser L and Gordon S: The function of
scavenger receptorsex-pressed by macrophages and their role in the
regulation of inflammation. Microbes Infect. 3:149–159. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Platt N, Haworth R, Darley L and Gordon S:
The many roles of the class A macrophage scavenger receptor. Int
Rev Cytol. 212:1–40. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Elomaa O, Sankala M, Pikkarainen T,
Bergmann U, Tuuttila A, Raatikainen-Ahokas A, Sariola H and
Tryggvason K: Structure of the human macrophage MARCO receptor and
characterization of its bacteria-binding region. J Biol Chem.
273:4530–4538. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han HJ, Tokino T and Nakamura Y: CSR, a
scavenger receptor-like protein with a protective role against
cellular damage caused by UV irradiation and oxidative stress. Hum
Mol Genet. 7:1039–1046. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohtani K, Suzuki Y, Eda S, Kawai T, Kase
T, Keshi H, Sakai Y, Fukuoh A, Sakamoto T, Itabe H, et al: The
membrane-type collectin CL-P1 is a scavenger receptor on vascular
endothelial cells. J Biol Chem. 276:44222–44228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang Y, Oliver P, Davies KE and Platt N:
Identification and characterization of murine SCARA5, a novel class
A scavenger receptor that is expressed by populations of epithelial
cells. J Biol Chem. 281:11834–11845. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Suzuki H, Kurihara Y, Takeya M, Kamada N,
Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, et
al: A role for macrophage scavenger receptors in atherosclerosis
and susceptibility to infection. Nature. 386:292–296. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu J, Hu G, Chen D, Gong AY, Soori GS,
Dobleman TJ and Chen XM: Suppression of SCARA5 by Snail1 is
essential for EMT-associated cell migration of A549 cells.
Oncogenesis. 2:e732013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huang J, Zheng DL, Qin FS, Cheng N, Chen
H, Wan BB, Wang YP, Xiao HS and Han ZG: Genetic and epigenetic
silencing of SCARA5 may contribute to human hepatocellular
carcinoma by activating FAK signaling. J Clin Invest. 120:223–241.
2010. View
Article : Google Scholar :
|
|
13
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
14
|
Kruger NJ: The Bradford method for protein
quantitation. Methods Mol Biol. 32:9–15. 1994.PubMed/NCBI
|
|
15
|
Sulzmaier FJ, Jean C and Schlaepfer DD:
FAK in cancer: Mechanistic findings and clinical applications. Nat
Rev Cancer. 14:598–610. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fingleton B: Matrix metalloproteinases:
Roles in cancer and metastasis. Front Biosci. 11:479–491. 2006.
View Article : Google Scholar
|
|
17
|
Yu G, Tseng GC, Yu YP, Gavel T, Nelson J,
Wells A, Michalopoulos G, Kokkinakis D and Luo JH: CSR1 suppresses
tumor growth and metastasis of prostate cancer. Am J Pathol.
168:597–607. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kurayoshi M, Oue N, Yamamoto H, Kishida M,
Inoue A, Asahara T, Yasui W and Kikuchi A: Expression of Wnt-5a is
correlated with aggressiveness of gastric cancer by stimulating
cell migration and invasion. Cancer Res. 66:10439–10448. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bock AJ, Nymoen DA, Brenne K, Kærn J and
Davidson B: SCARA3 mRNA is overexpressed in ovarian carcinoma
compared with breast carcinoma effusions. Hum Pathol. 43:669–674.
2012. View Article : Google Scholar
|
|
20
|
Sieg DJ, Hauck CR, Ilic D, Klingbeil CK,
Schaefer E, Damsky CH and Schlaepfer DD: FAK integrates
growth-factor and integrin signals to promote cell migration. Nat
Cell Biol. 2:249–256. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tilghman RW and Parsons JT: Focal adhesion
kinase as a regulator of cell tension in the progression of cancer.
Semin Cancer Biol. 18:45–52. 2008. View Article : Google Scholar
|
|
22
|
Schlaepfer DD, Mitra SK and Ilic D:
Control of motile and invasive cell phenotypes by focal adhesion
kinase. Biochim Biophys Acta. 1692:77–102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seong BK, Lau J, Adderley T, Kee L,
Chaukos D, Pienkowska M, Malkin D, Thorner P and Irwin MS: SATB2
enhances migration and invasion in osteosarcoma by regulating genes
involved in cytoskeletal organization. Oncogene. 34:3582–3592.
2015. View Article : Google Scholar
|
|
24
|
Hu Y, Xu S, Jin W, Yi Q and Wei W: Effect
of the PTEN gene on adhesion, invasion and metastasis of
osteosarcoma cells. Oncol Rep. 32:1741–1747. 2014.PubMed/NCBI
|
|
25
|
Park GB, Kim DJ, Kim YS, Lee HK, Kim CW
and Hur DY: Silencing of galectin-3 represses osteosarcoma cell
migration and invasion through inhibition of FAK/Src/Lyn activation
and β-catenin expression and increases susceptibility to
chemotherapeutic agents. Int J Oncol. 46:185–194. 2015.
|
|
26
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kido A, Tsutsumi M, Iki K, Takahama M,
Tsujiuchi T, Morishita T, Tamai S and Konishi Y: Overexpression of
matrix metalloproteinase (MMP)-9 correlates with metastatic potency
of spontaneous and 4-hydroxyaminoquinoline 1-oxide (4-HAQO)-induced
transplantable osteosarcomas in rats. Cancer lett. 137:209–216.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Himelstein BP, Asada N, Carlton MR and
Collins MH: Matrix metalloproteinase·9 (MMP·9) expression in
childhood osseous osteosarcoma. Med Pediatr Oncol. 31:471–474.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Uchibori M, Nishida Y, Nagasaka T, Yamada
Y, Nakanishi K and Ishiguro N: Increased expression of
membrane-type matrix metalloproteinase-1 is correlated with poor
prognosis in patients with osteosarcoma. Int J Oncol. 28:33–42.
2006.
|
